chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria, Vaccination site erythema
Clinical narrative: injection site redness; hives; rash; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site redness), URTICARIA (hives) and RASH (rash) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19.     No medical history was provided by reporter.     On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site redness), URTICARIA (hives) and RASH (rash). At the time of the report, VACCINATION SITE ERYTHEMA (injection site redness), URTICARIA (hives) and RASH (rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided by reporter  No treatment was reported.   Reporter did not allow further contact
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Fatigue, Headache, Night sweats
Clinical narrative: night sweats; Light headache; dizziness; loss of appetite; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Light headache), DIZZINESS (dizziness), DECREASED APPETITE (loss of appetite), FATIGUE (tiredness) and NIGHT SWEATS (night sweats) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20) for COVID-19 vaccination.     No medical history was provided by reporter.     On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced HEADACHE (Light headache), DIZZINESS (dizziness), DECREASED APPETITE (loss of appetite) and FATIGUE (tiredness). On 15-Feb-2021, the patient experienced NIGHT SWEATS (night sweats). On 17-Feb-2021, NIGHT SWEATS (night sweats) outcome was unknown. At the time of the report, HEADACHE (Light headache), DIZZINESS (dizziness), DECREASED APPETITE (loss of appetite) and FATIGUE (tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.    Laboratory details were not provided. No treatment information was provided.    This case was linked to MOD-2021-015841 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD-2021-015841:master case - same reporter, different patient
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Neuropathy peripheral, Paraesthesia
Clinical narrative: pins and needles on the left side of the face; tingling sensation on face; burning sensation on face; A spontaneous report was received from a health care professional (nurse) concerning a 54 years old female who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events, peripheral neuropathy, tingling, burning sensation.  The patient's medical history provided was chronic interstitial cystitis.  Concomitant medication reported was gabapentin.  On 26 Dec 2020 prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 026L20A) for prophylaxis of COVID-19 infection. On 23 Jan 2021, the patient received the second dose of the Moderna vaccine on 23Jan2021 (Lot number: 032L20A).  On 23/Jan/2021 the patient experienced peripheral neuropathy, tingling, burning sensation.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Chills, Dizziness, Fatigue, Pruritus
Clinical narrative: allergic reaction; itchy; Dizziness; Chills; Tired; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), ALLERGY TO VACCINE (allergic reaction), PRURITUS (itchy), FATIGUE (Tired) and CHILLS (Chills) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029LZ0A) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concurrent medical conditions included Food allergy (Unspecified).   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 30-Jan-2021, the patient experienced FATIGUE (Tired).   On 02-Feb-2021, the patient experienced DIZZINESS (Dizziness) and CHILLS (Chills). On an unknown date, the patient experienced ALLERGY TO VACCINE (allergic reaction) and PRURITUS (itchy).   At the time of the report, DIZZINESS (Dizziness), ALLERGY TO VACCINE (allergic reaction), PRURITUS (itchy), FATIGUE (Tired) and CHILLS (Chills) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Palpitations, Vaccination site pain
Clinical narrative: felt a little racy; sore spot near the vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (felt a little racy) and VACCINATION SITE PAIN (sore spot near the vaccination site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Lung cancer. Concurrent medical conditions included White clot syndrome.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (felt a little racy) and VACCINATION SITE PAIN (sore spot near the vaccination site). At the time of the report, PALPITATIONS (felt a little racy) had resolved and VACCINATION SITE PAIN (sore spot near the vaccination site) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: increase (High) Recoverd/Resolved.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was provide to the patient .    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Oropharyngeal discomfort, Palpitations, Pharyngeal swelling
Clinical narrative: felt like a was marble was in throat; hurt to swallow; it felt swollen; fast heart beat 120 beats per minute; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (fast heart beat 120 beats per minute), OROPHARYNGEAL DISCOMFORT (felt like a was marble was in throat), DYSPHAGIA (hurt to swallow) and PHARYNGEAL SWELLING (it felt swollen) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced PALPITATIONS (fast heart beat 120 beats per minute). On 15-Feb-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (felt like a was marble was in throat), DYSPHAGIA (hurt to swallow) and PHARYNGEAL SWELLING (it felt swollen). At the time of the report, PALPITATIONS (fast heart beat 120 beats per minute), OROPHARYNGEAL DISCOMFORT (felt like a was marble was in throat), DYSPHAGIA (hurt to swallow) and PHARYNGEAL SWELLING (it felt swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       There were no Concomitant Medication used by the patient   Reporter did not allow further contact
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Exposure during pregnancy, Ultrasound antenatal screen normal
Clinical narrative: Vaccine exposure during pregnancy; A spontaneous report was received from a consumer who was also a 22-years-old female patient who received Moderna's COVID-19 vaccine during pregnancy.    Patient's medical history include Allergies, Anxiety  Eczema and consumption of alcohol also one previous pregnancy(normal, Live full term birth), and concomitant medicines taken by the patient, are Zyrtec 10mg QD, PO (Allergy), Zoloft 50mg QD, PO (anxiety), Stool softener 100mg PRN, PO (Constipation) and  Prenatal vitamins.   The blood test, ultrasound and genetic test  were normal.  Pregnancy details: LMP- 10-NOV-2021, Estimated date of consumption- 25-nov-2020, estimated due date : 23-may-2021. G2P1  On 15/Jan/2021, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the upper arm for prophylaxis of COVID-19 infection.  On 12/Feb/2021 the patient received their second of two planned doses of mRNA-1273 intramuscularly in the upper arm for prophylaxis of COVID-19 infection.   The outcome of the events, exposure during pregnancy is unknown.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Injection site swelling, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (arm hot to touch), MYALGIA (muscle pain) and INJECTION SITE SWELLING (mark at injection site size of a fist) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (no medical history provided).    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (arm hot to touch), MYALGIA (muscle pain) and INJECTION SITE SWELLING (mark at injection site size of a fist). At the time of the report, FEELING HOT (arm hot to touch), MYALGIA (muscle pain) and INJECTION SITE SWELLING (mark at injection site size of a fist) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient is taking blood pressure medication as concomitant no treatment taken
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Influenza like illness, Migraine, Pain
Clinical narrative: Migraine headache; fever; chills; Body ache; "Flu-like" symptoms; Back was killing; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine headache), PYREXIA (fever), CHILLS (chills), PAIN (Body ache) and INFLUENZA LIKE ILLNESS ("Flu-like" symptoms) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030220A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history provided).    On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 17-Feb-2021, the patient experienced MIGRAINE (Migraine headache), PYREXIA (fever), CHILLS (chills), PAIN (Body ache), INFLUENZA LIKE ILLNESS ("Flu-like" symptoms) and BACK PAIN (Back was killing). At the time of the report, MIGRAINE (Migraine headache), PYREXIA (fever), CHILLS (chills), PAIN (Body ache), INFLUENZA LIKE ILLNESS ("Flu-like" symptoms) and BACK PAIN (Back was killing) was resolving. Not Provided          Patient has  taken 2 Tylenol ,pharmacist who recommended , feels better
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Migraine headache; fever; chills; Body ache; "Flu-like" symptoms; Back was killing; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine headache), PYREXIA (fever), CHILLS (chills), PAIN (Body ache) and INFLUENZA LIKE ILLNESS ("Flu-like" symptoms) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030220A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history provided).    On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 17-Feb-2021, the patient experienced MIGRAINE (Migraine headache), PYREXIA (fever), CHILLS (chills), PAIN (Body ache), INFLUENZA LIKE ILLNESS ("Flu-like" symptoms) and BACK PAIN (Back was killing). At the time of the report, MIGRAINE (Migraine headache), PYREXIA (fever), CHILLS (chills), PAIN (Body ache), INFLUENZA LIKE ILLNESS ("Flu-like" symptoms) and BACK PAIN (Back was killing) was resolving. Not Provided          Patient has  taken 2 Tylenol ,pharmacist who recommended , feels better
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Induration, Pruritus, Rash
Clinical narrative: rash; itches; Redness moving down the arm.; Hardness moving down the arm.; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash), PRURITUS (itches), ERYTHEMA (Redness moving down the arm.) and INDURATION (Hardness moving down the arm.) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history).    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rash), PRURITUS (itches), ERYTHEMA (Redness moving down the arm.) and INDURATION (Hardness moving down the arm.). At the time of the report, RASH (rash), PRURITUS (itches), ERYTHEMA (Redness moving down the arm.) and INDURATION (Hardness moving down the arm.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no concomitant medication given patient has taken Diphenhydramine HCl to mitigate the symptoms
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test, Ultrasound abdomen
Clinical narrative: maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Alcohol use (3drink /week stop date-08 Jul 2021.).   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 13-Jun-2020 and the estimated date of delivery was 20-Mar-2021. On 16-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-first week of the pregnancy. The vaginal delivery occurred on 19-Mar-2021, which was reported as Full-term. For neonate 1, the birth weight was 2980 grams (6lbs 9oz). The outcome was reported as Unknown. Female Baby Head circumference is 34cm, length was 49.53cm. The patient was treated with MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) ongoing from 01-Jan-2021 at an unspecified dose and frequency. On 16-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jul-2021, Pregnancy test: positive positive. On an unknown date, Ultrasound abdomen: normal (normal) normal.         Concomitant products included one-a- day prenatal vitamin with start date of 01Jan2020 and is Ongoing. No Treatment history was provided by the reporter. Lab data during pregnancy included Glucose, ultrasounds which were normal Estimated date of conception- 27 JUN 2021, Patient is currently breastfeeding, no abnormalities on delivery and 1 month post-partum.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Pregnancy outcome form with additional information attached.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: arm started itching; red mark; A spontaneous report was received from a  Consumer concerning a 71 Years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced arm started itching(Pruritus), red mark(Erythema).  The patient's medical history was not provided. Atorvastatin 10 mg, Levothyroxine 50 mcg, Eye drop for glaucoma concomitant medications were reported.  On 09 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch Number: 013M20A) intramuscularly in the arm  for prophylaxis of COVID-19 infection.  On 16 Feb 2021, the patient experience the starting of arm  itching and  the red mark appearance.  The patient was treated with Benadryl pill and Benadryl cream for arm itching and for red mark.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the events was not resolved.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Heart rate, Influenza like illness
Clinical narrative: A really terrible feeling, feeling really sick; Had the worst shivering; Flu-like symptoms; Used a walker; Dizziness; Fatigue; Ready to throw up; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (A really terrible feeling, feeling really sick), CHILLS (Had the worst shivering), INFLUENZA LIKE ILLNESS (Flu-like symptoms), WALKING AID USER (Used a walker) and DIZZINESS (Dizziness) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (A really terrible feeling, feeling really sick), CHILLS (Had the worst shivering), INFLUENZA LIKE ILLNESS (Flu-like symptoms), WALKING AID USER (Used a walker), DIZZINESS (Dizziness), FATIGUE (Fatigue) and NAUSEA (Ready to throw up). The patient was treated with GINGER [ZINGIBER OFFICINALE RHIZOME] (GINGER CAPSULE [ZINGIBER OFFICINALE RHIZOME]) for Nausea, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (A really terrible feeling, feeling really sick), CHILLS (Had the worst shivering), INFLUENZA LIKE ILLNESS (Flu-like symptoms), WALKING AID USER (Used a walker), DIZZINESS (Dizziness), FATIGUE (Fatigue) and NAUSEA (Ready to throw up) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Heart rate: high (High) 96 BEATS IN SITTING POSITION 105 BEATS FOR SECOND TIME.         Patient could not sleep in any position beacause of pain and also she vaccinated the place where she took small pox vaccine which is in younger
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination complication, Walking aid user
Clinical narrative: A really terrible feeling, feeling really sick; Had the worst shivering; Flu-like symptoms; Used a walker; Dizziness; Fatigue; Ready to throw up; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (A really terrible feeling, feeling really sick), CHILLS (Had the worst shivering), INFLUENZA LIKE ILLNESS (Flu-like symptoms), WALKING AID USER (Used a walker) and DIZZINESS (Dizziness) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (A really terrible feeling, feeling really sick), CHILLS (Had the worst shivering), INFLUENZA LIKE ILLNESS (Flu-like symptoms), WALKING AID USER (Used a walker), DIZZINESS (Dizziness), FATIGUE (Fatigue) and NAUSEA (Ready to throw up). The patient was treated with GINGER [ZINGIBER OFFICINALE RHIZOME] (GINGER CAPSULE [ZINGIBER OFFICINALE RHIZOME]) for Nausea, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (A really terrible feeling, feeling really sick), CHILLS (Had the worst shivering), INFLUENZA LIKE ILLNESS (Flu-like symptoms), WALKING AID USER (Used a walker), DIZZINESS (Dizziness), FATIGUE (Fatigue) and NAUSEA (Ready to throw up) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Heart rate: high (High) 96 BEATS IN SITTING POSITION 105 BEATS FOR SECOND TIME.         Patient could not sleep in any position beacause of pain and also she vaccinated the place where she took small pox vaccine which is in younger
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Asthenia, Dyspnoea, Hyperhidrosis, Nausea
Clinical narrative: started to sweat quite a bit; really weak for 2 days; had body aches; trouble breathing; a pretty bad reaction; had nausea; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (started to sweat quite a bit), ASTHENIA (really weak for 2 days), PAIN (had body aches), DYSPNOEA (trouble breathing) and ADVERSE REACTION (a pretty bad reaction) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal, Cholesterol total abnormal NOS and Thyroid disorder NOS.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced HYPERHIDROSIS (started to sweat quite a bit), ASTHENIA (really weak for 2 days), PAIN (had body aches), DYSPNOEA (trouble breathing), ADVERSE REACTION (a pretty bad reaction) and NAUSEA (had nausea). On 15-Feb-2021, ASTHENIA (really weak for 2 days) had resolved. At the time of the report, HYPERHIDROSIS (started to sweat quite a bit), PAIN (had body aches), DYSPNOEA (trouble breathing), ADVERSE REACTION (a pretty bad reaction) and NAUSEA (had nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications as medications for blood pressure, thyroid and cholesterol No Treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 18-Feb-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: started to sweat quite a bit; really weak for 2 days; had body aches; trouble breathing; a pretty bad reaction; had nausea; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (started to sweat quite a bit), ASTHENIA (really weak for 2 days), PAIN (had body aches), DYSPNOEA (trouble breathing) and ADVERSE REACTION (a pretty bad reaction) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal, Cholesterol total abnormal NOS and Thyroid disorder NOS.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced HYPERHIDROSIS (started to sweat quite a bit), ASTHENIA (really weak for 2 days), PAIN (had body aches), DYSPNOEA (trouble breathing), ADVERSE REACTION (a pretty bad reaction) and NAUSEA (had nausea). On 15-Feb-2021, ASTHENIA (really weak for 2 days) had resolved. At the time of the report, HYPERHIDROSIS (started to sweat quite a bit), PAIN (had body aches), DYSPNOEA (trouble breathing), ADVERSE REACTION (a pretty bad reaction) and NAUSEA (had nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications as medications for blood pressure, thyroid and cholesterol No Treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 18-Feb-2021: No specific follow-up information recorded.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Fatigue, Lethargy, Mass, Pain in extremity
Clinical narrative: Knot there in my arm area; Spot on her left temple like a pimple or a blister; Lethargic; Fever shot up; Fatigued; Arm swelled up; Sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PYREXIA (Fever shot up), FATIGUE (Fatigued), PERIPHERAL SWELLING (Arm swelled up), PAIN IN EXTREMITY (Sore) and MASS (Knot there in my arm area) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 and Allergy (Aspirin salts.) since an unknown date.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced PYREXIA (Fever shot up), FATIGUE (Fatigued), PERIPHERAL SWELLING (Arm swelled up), PAIN IN EXTREMITY (Sore) and LETHARGY (Lethargic). On an unknown date, the patient experienced MASS (Knot there in my arm area) and BLISTER (Spot on her left temple like a pimple or a blister). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and NAPHAZOLINE HYDROCHLORIDE (EYE DROPS [NAPHAZOLINE HYDROCHLORIDE]) for Blister, at an unspecified dose and frequency. On 24-Jan-2021, PYREXIA (Fever shot up), FATIGUE (Fatigued) and LETHARGY (Lethargic) had resolved. At the time of the report, PERIPHERAL SWELLING (Arm swelled up), PAIN IN EXTREMITY (Sore), MASS (Knot there in my arm area) and BLISTER (Spot on her left temple like a pimple or a blister) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no concomitant medication provided patient called for her eye doctor and who gave her eyedrops which she using.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia
Clinical narrative: Knot there in my arm area; Spot on her left temple like a pimple or a blister; Lethargic; Fever shot up; Fatigued; Arm swelled up; Sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PYREXIA (Fever shot up), FATIGUE (Fatigued), PERIPHERAL SWELLING (Arm swelled up), PAIN IN EXTREMITY (Sore) and MASS (Knot there in my arm area) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 and Allergy (Aspirin salts.) since an unknown date.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced PYREXIA (Fever shot up), FATIGUE (Fatigued), PERIPHERAL SWELLING (Arm swelled up), PAIN IN EXTREMITY (Sore) and LETHARGY (Lethargic). On an unknown date, the patient experienced MASS (Knot there in my arm area) and BLISTER (Spot on her left temple like a pimple or a blister). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and NAPHAZOLINE HYDROCHLORIDE (EYE DROPS [NAPHAZOLINE HYDROCHLORIDE]) for Blister, at an unspecified dose and frequency. On 24-Jan-2021, PYREXIA (Fever shot up), FATIGUE (Fatigued) and LETHARGY (Lethargic) had resolved. At the time of the report, PERIPHERAL SWELLING (Arm swelled up), PAIN IN EXTREMITY (Sore), MASS (Knot there in my arm area) and BLISTER (Spot on her left temple like a pimple or a blister) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no concomitant medication provided patient called for her eye doctor and who gave her eyedrops which she using.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Injection site erythema, Injection site pruritus, Injection site swelling, Pyrexia
Clinical narrative: Lump red area around the injection site; Fever of 101; Flu like symptoms; left arm swelling; injection site itchy; injection site swelling; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Lump red area around the injection site), PYREXIA (Fever of 101), INFLUENZA LIKE ILLNESS (Flu like symptoms), SWELLING (left arm swelling) and INJECTION SITE PRURITUS (injection site itchy) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history found).   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (Lump red area around the injection site), PYREXIA (Fever of 101), INFLUENZA LIKE ILLNESS (Flu like symptoms), SWELLING (left arm swelling), INJECTION SITE PRURITUS (injection site itchy) and INJECTION SITE SWELLING (injection site swelling). At the time of the report, INJECTION SITE ERYTHEMA (Lump red area around the injection site), PYREXIA (Fever of 101), INFLUENZA LIKE ILLNESS (Flu like symptoms), SWELLING (left arm swelling), INJECTION SITE PRURITUS (injection site itchy) and INJECTION SITE SWELLING (injection site swelling) outcome was unknown.            no concomitant medication and treatment provided   This case was linked to MOD-2021-016248 (Patient Link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Lump red area around the injection site; Fever of 101; Flu like symptoms; left arm swelling; injection site itchy; injection site swelling; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Lump red area around the injection site), PYREXIA (Fever of 101), INFLUENZA LIKE ILLNESS (Flu like symptoms), SWELLING (left arm swelling) and INJECTION SITE PRURITUS (injection site itchy) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history found).   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (Lump red area around the injection site), PYREXIA (Fever of 101), INFLUENZA LIKE ILLNESS (Flu like symptoms), SWELLING (left arm swelling), INJECTION SITE PRURITUS (injection site itchy) and INJECTION SITE SWELLING (injection site swelling). At the time of the report, INJECTION SITE ERYTHEMA (Lump red area around the injection site), PYREXIA (Fever of 101), INFLUENZA LIKE ILLNESS (Flu like symptoms), SWELLING (left arm swelling), INJECTION SITE PRURITUS (injection site itchy) and INJECTION SITE SWELLING (injection site swelling) outcome was unknown.            no concomitant medication and treatment provided   This case was linked to MOD-2021-016248 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling
Clinical narrative: Swelling of the joints after first dose; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of JOINT SWELLING (Swelling of the joints after first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Adverse event (no medical history provided).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced JOINT SWELLING (Swelling of the joints after first dose). The patient was treated with MELOXICAM at an unspecified dose and frequency and METHYLPREDNISOLONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, JOINT SWELLING (Swelling of the joints after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no concomitant medication patient is first on treatment meloxicam and her doctor has changed to methylprednisolone but told to wait until 2 weeks before getting vaccine   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: swelling on my neck; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling on my neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Non-Hodgkin's lymphoma.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced SWELLING (swelling on my neck). At the time of the report, SWELLING (swelling on my neck) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Fatigue, Gait disturbance, Nausea
Clinical narrative: Fatigue; loss of sensation on legs; Nausea; Shoulder pain; Walking difficulty; weakness in morning; This spontaneous case was reported by a patient and describes the occurrence of NAUSEA (Nausea), FATIGUE (fatigue), SENSORY LOSS (loss of sensation on legs), GAIT DISTURBANCE (walking difficulty) and ARTHRALGIA (shoulder pain) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced NAUSEA (Nausea), FATIGUE (fatigue), SENSORY LOSS (loss of sensation on legs), GAIT DISTURBANCE (walking difficulty), ARTHRALGIA (shoulder pain) and ASTHENIA (weakness in morning). At the time of the report, NAUSEA (Nausea), FATIGUE (fatigue), SENSORY LOSS (loss of sensation on legs), GAIT DISTURBANCE (walking difficulty), ARTHRALGIA (shoulder pain) and ASTHENIA (weakness in morning) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Sensory loss
Clinical narrative: Fatigue; loss of sensation on legs; Nausea; Shoulder pain; Walking difficulty; weakness in morning; This spontaneous case was reported by a patient and describes the occurrence of NAUSEA (Nausea), FATIGUE (fatigue), SENSORY LOSS (loss of sensation on legs), GAIT DISTURBANCE (walking difficulty) and ARTHRALGIA (shoulder pain) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced NAUSEA (Nausea), FATIGUE (fatigue), SENSORY LOSS (loss of sensation on legs), GAIT DISTURBANCE (walking difficulty), ARTHRALGIA (shoulder pain) and ASTHENIA (weakness in morning). At the time of the report, NAUSEA (Nausea), FATIGUE (fatigue), SENSORY LOSS (loss of sensation on legs), GAIT DISTURBANCE (walking difficulty), ARTHRALGIA (shoulder pain) and ASTHENIA (weakness in morning) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Diarrhoea, Heart rate, Heart rate increased
Clinical narrative: Elevated Blood Pressure; Elevated Pulse; DIARRHOEA; Felt like had "Flu or COVID"; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like had "Flu or COVID"), BLOOD PRESSURE INCREASED (Elevated Blood Pressure), HEART RATE INCREASED (Elevated Pulse) and DIARRHOEA (DIARRHOEA) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Pulse abnormal. Concomitant products included ALLOPURINOL (ELAVIL [ALLOPURINOL]) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like had "Flu or COVID"), HEART RATE INCREASED (Elevated Pulse) and DIARRHOEA (DIARRHOEA). On an unknown date, the patient experienced BLOOD PRESSURE INCREASED (Elevated Blood Pressure). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, INFLUENZA LIKE ILLNESS (Felt like had "Flu or COVID") and DIARRHOEA (DIARRHOEA) had resolved and BLOOD PRESSURE INCREASED (Elevated Blood Pressure) and HEART RATE INCREASED (Elevated Pulse) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 150/100 (High) 150/100. On an unknown date, Heart rate: 100 (High) 100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Elevated Blood Pressure; Elevated Pulse; DIARRHOEA; Felt like had "Flu or COVID"; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like had "Flu or COVID"), BLOOD PRESSURE INCREASED (Elevated Blood Pressure), HEART RATE INCREASED (Elevated Pulse) and DIARRHOEA (DIARRHOEA) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Pulse abnormal. Concomitant products included ALLOPURINOL (ELAVIL [ALLOPURINOL]) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like had "Flu or COVID"), HEART RATE INCREASED (Elevated Pulse) and DIARRHOEA (DIARRHOEA). On an unknown date, the patient experienced BLOOD PRESSURE INCREASED (Elevated Blood Pressure). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, INFLUENZA LIKE ILLNESS (Felt like had "Flu or COVID") and DIARRHOEA (DIARRHOEA) had resolved and BLOOD PRESSURE INCREASED (Elevated Blood Pressure) and HEART RATE INCREASED (Elevated Pulse) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 150/100 (High) 150/100. On an unknown date, Heart rate: 100 (High) 100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Lot of soreness around the injected area; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (lot of soreness around the injected area) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure, Thyroid disorder and Dementia. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced INJECTION SITE PAIN (lot of soreness around the injected area). At the time of the report, INJECTION SITE PAIN (lot of soreness around the injected area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: Fever; injection site is red; Injection site itchy; Rash on her left arm just below the injection site; Injection site was hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site was hot to the touch), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE RASH (Rash on her left arm just below the injection site), VACCINATION SITE ERYTHEMA (Injection site is red) and PYREXIA (Fever) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M201A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Injection site was hot to the touch), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE RASH (Rash on her left arm just below the injection site) and VACCINATION SITE ERYTHEMA (Injection site is red). On 31-Jan-2021, the patient experienced PYREXIA (Fever). At the time of the report, VACCINATION SITE WARMTH (Injection site was hot to the touch), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE RASH (Rash on her left arm just below the injection site), VACCINATION SITE ERYTHEMA (Injection site is red) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Headache
Clinical narrative: difficulty breathing; headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and DYSPNOEA (difficulty breathing) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced HEADACHE (headache) and DYSPNOEA (difficulty breathing). At the time of the report, HEADACHE (headache) and DYSPNOEA (difficulty breathing) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness in his arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness in his arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness in his arm). At the time of the report, VACCINATION SITE PAIN (soreness in his arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pain, Pyrexia, Rash
Clinical narrative: bumpy rash(size of coin); flu like symptoms; fever of 101; Achy; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (fever of 101), PAIN (Achy) and RASH (bumpy rash(size of coin)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Autoimmune disorder.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (fever of 101) and PAIN (Achy). On 30-Jan-2021, the patient experienced RASH (bumpy rash(size of coin)). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (fever of 101) and PAIN (Achy) had resolved and RASH (bumpy rash(size of coin)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Malaise, Pyrexia
Clinical narrative: loss of taste; loss of smell; running fever 101°F; FEELING SICK; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (FEELING SICK), AGEUSIA (loss of taste), ANOSMIA (loss of smell) and PYREXIA (running fever 101°F) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19.     Concurrent medical conditions included Hypertension.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced MALAISE (FEELING SICK) and PYREXIA (running fever 101°F). On 04-Feb-2021, the patient experienced AGEUSIA (loss of taste) and ANOSMIA (loss of smell). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DEXTROMETHORPHAN POLISTIREX (ROBITUSSIN 12 HOUR COUGH RELIEF) at an unspecified dose and frequency. At the time of the report, MALAISE (FEELING SICK) and PYREXIA (running fever 101°F) had resolved and AGEUSIA (loss of taste) and ANOSMIA (loss of smell) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include Blood Pressure Medication.